bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.4900
-0.0220 (-4.30%)
Apr 25, 2025, 12:53 PM EDT - Market open
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $8.77 million as of April 25, 2025. Its market cap has decreased by -70.80% in one year.
Market Cap
8.77M
Enterprise Value
9.56M
1-Year Change
-70.80%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $8.77M, a decrease of -80.51%. That is a compound annual growth rate of -46.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 9.17M | -35.35% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.27B |
| UnitedHealth Group | 379.67B |
| Johnson & Johnson | 369.48B |
| AbbVie | 328.20B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.98B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |